How to eradicate Clostridium difficile from the environment

Journal of Hospital Infection

Volumn 89, Issue 4, 2015, Pages 287-295

  Barbut, F ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Clostridium difficile; Disinfection; Hospital infection

Indexed keywords

AMMONIA; CHLORINE DIOXIDE; HYDROGEN PEROXIDE; HYPOCHLORITE; DISINFECTANT AGENT;

BACTERIAL CLEARANCE; BACTERIAL SPORE; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE INFECTION; DISINFECTION; DISINFECTION SYSTEM; HOSPITAL INFECTION; HUMAN; INFECTION RISK; NONHUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; SHORT SURVEY; ULTRAVIOLET C RADIATION; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DRUG EFFECTS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISINFECTANTS; DISINFECTION; ENVIRONMENTAL MICROBIOLOGY; HUMANS; INFECTION CONTROL; ULTRAVIOLET RAYS;

EID: 84933180259     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.12.007     Document Type: Short Survey

References (62)

1. Zarb P., Coignard B., Griskeviciene J., et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 2012, 17(46).
2. Davies KA, Davis GL, Ashwin HM, Lee F, Longshaw CM, Wilcox MH. Second report from the European, multi-centre, prospective bi-annual point prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). 24th European Congress of Clinical Microbiology and Infectious Disease, Barcelona, 2014.
3. Magill S.S., Edwards J.R., Bamberg W., et al. Multistate point-prevalence survey of health care-associated infections. NEngl J Med 2014, 370:1198-1208.
4. US Centers for Disease Control and Prevention Antibiotic resistance threats in the United States, 2013 2013, US Department of Heath and Human Services, Atlanta.
5. Gabriel L., Beriot-Mathiot A. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. JHosp Infect 2014, 88:12-21.
6. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl. 6):2-18.
7. Dubberke E.R., Reske K.A., Olsen M.A., McDonald L.C., Fraser V.J. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46:497-504.
8. O'Brien J.A., Lahue B.J., Caro J.J., Davidson D.M. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007, 28:1219-1227.
9. Loo V.G., Bourgault A.M., Poirier L., et al. Host and pathogen factors for Clostridium difficile infection and colonization. NEngl J Med 2011, 365:1693-1703.
10. Kim K.H., Fekety R., Batts D.H., et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. JInfect Dis 1981, 143:42-50.
11. Samore M.H., Venkataraman L., DeGirolami P.C., Arbeit R.D., Karchmer A.W. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996, 100:32-40.
12. McFarland L.V., Mulligan M.E., Kwok R.Y., Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. NEngl J Med 1989, 320:204-210.
13. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L., Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007, 45:992-998.
14. Best E.L., Fawley W.N., Parnell P., Wilcox M.H. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 2010, 50:1450-1457.
15. Boyce J.M., Havill N.L., Otter J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008, 29:723-729.
16. Claro T., Daniels S., Humphreys H. Detecting Clostridium difficile spores from inanimate surfaces of the hospital environment: which method is best?. JClin Microbiol 2014, 52:3426-3428.
17. Lawley T.D., Clare S., Deakin L.J., et al. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 2010, 76:6895-6900.
18. Otter J.A., French G.L. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. JClin Microbiol 2009, 47:205-207.
19. Wagenvoort J.H., De Brauwer E.I., Penders R.J., Willems R.J., Top J., Bonten M.J. Environmental survival of vancomycin-resistant Enterococcus faecium. JHosp Infect 2011, 77:282-283.
20. Fawley W.N., Underwood S., Freeman J., et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 2007, 28:920-925.
21. Shaughnessy M.K., Micielli R.L., DePestel D.D., et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011, 32:201-206.
22. Rebmann T., Carrico R.M., Association for Professionals in Infection Control and Epidemiology Preventing Clostridium difficile infections: an executive summary of the Association for Professionals in Infection Control and Epidemiology's elimination guide. Am J Infect Control 2011, 39:239-242.
23. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
24. Dubberke E.R., Carling P., Carrico R., et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014, 35:628-645.
25. Vonberg R.P., Kuijper E.J., Wilcox M.H., et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008, 14(Suppl. 5):2-20.
26. Curry S.R., Muto C.A., Schlackman J.L., et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013, 57:1094-1102.
27. Perez J., Springthorpe V.S., Sattar S.A. Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. Am J Infect Control 2005, 33:320-325.
28. Speight S., Moy A., Macken S., et al. Evaluation of the sporicidal activity of different chemical disinfectants used in hospitals against Clostridium difficile. JHosp Infect 2011, 79:18-22.
29. Kaatz G.W., Gitlin S.D., Schaberg D.R., et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988, 127:1289-1294.
30. Mayfield J.L., Leet T., Miller J., Mundy L.M. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000, 31:995-1000.
31. Wilcox M.H., Fawley W.N., Wigglesworth N., Parnell P., Verity P., Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. JHosp Infect 2003, 54:109-114.
32. McMullen K.M., Zack J., Coopersmith C.M., Kollef M., Dubberke E., Warren D.K. Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2007, 28:205-207.
33. Hacek D.M., Ogle A.M., Fisher A., Robicsek A., Peterson L.R. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control 2010, 38:350-353.
34. Manian F.A., Griesnauer S., Bryant A. Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms and its impact on endemic Clostridium difficile infection rates. Am J Infect Control 2013, 41:537-541.
35. Orenstein R., Aronhalt K.C., McManus J.E., Fedraw L.A. Atargeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol 2011, 32:1137-1139.
36. Passaretti C.L., Otter J.A., Reich N.G., et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2012, 56:27-35.
37. Levin J., Riley L.S., Parrish C., English D., Ahn S. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. Am J Infect Control 2013, 41:746-748.
38. Barbut F., Menuet D., Verachten M., Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009, 30:507-514.
39. Carling P.C., Parry M.F., Von Beheren S.M. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol 2008, 29:1-7.
40. Carling P.C., Von Beheren S., Kim P., Woods C. Intensive care unit environmental cleaning: an evaluation in sixteen hospitals using a novel assessment tool. JHosp Infect 2008, 68:39-44.
41. Eckstein B.C., Adams D.A., Eckstein E.C., et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007, 7:61.
42. Boyce J.M., Havill N.L., Moore B.A. Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol 2011, 32:737-742.
43. Nerandzic M.M., Cadnum J.L., Pultz M.J., Donskey C.J. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010, 10:197.
44. Rutala W.A., Weber D.J. Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol 2010, 31:107-117.
45. Barbut F., Yezli S., Otter J.A. Activity invitro of hydrogen peroxide vapour against Clostridium difficile spores. JHosp Infect 2012, 80:85-87.
46. Fu T.Y., Gent P., Kumar V. Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. JHosp Infect 2012, 80:199-205.
47. Havill N.L., Moore B.A., Boyce J.M. Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination. Infect Control Hosp Epidemiol 2012, 33:507-512.
48. Nerandzic M.M., Cadnum J.L., Eckart K.E., Donskey C.J. Evaluation of a hand-held far-ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens. BMC Infect Dis 2012, 12:120.
49. Anderson D.J., Gergen M.F., Smathers E., et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol 2013, 34:466-471.
50. Haas J.P., Menz J., Dusza S., Montecalvo M.A. Implementation and impact of ultraviolet environmental disinfection in an acute care setting. Am J Infect Control 2014, 42:586-590.
51. Linley E., Denyer S.P., McDonnell G., Simons C., Maillard J.Y. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. JAntimicrob Chemother 2012, 67:1589-1596.
52. Hall L., Otter J.A., Chewins J., Wengenack N.L. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. JClin Microbiol 2007, 45:810-815.
53. Holmdahl T., Lanbeck P., Wullt M., Walder M.H. Ahead-to-head comparison of hydrogen peroxide vapor and aerosol room decontamination systems. Infect Control Hosp Epidemiol 2011, 32:831-836.
54. Shapey S., Machin K., Levi K., Boswell T.C. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect 2008, 70:136-141.
55. Boyce J.M. Environmental contamination makes an important contribution to hospital infection. JHosp Infect 2007, 65(Suppl. 2):50-54.
56. Cooper T., O'Leary M., Yezli S., Otter J.A. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. JHosp Infect 2011, 78:238-240.
57. Otter J.A., Barnicoat M., Down J., Smyth D., Yezli S., Jeanes A. Hydrogen peroxide vapour decontamination of a critical care unit room used to treat a patient with Lassa fever. JHosp Infect 2010, 75:335-337.
58. Barbut F., Yezli S., Mimoun M., Pham J., Chaouat M., Otter J.A. Reducing the spread of Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus on a burns unit through the intervention of an infection control bundle. Burns 2013, 39:395-403.
59. Boyce J.M., Havill N.L., Cianci V., Flanagan G. Compatibility of hydrogen peroxide vapor room decontamination with physiological monitors. Infect Control Hosp Epidemiol 2014, 35:92-93.
60. Moat J., Cargill J., Shone J., Upton M. Application of a novel decontamination process using gaseous ozone. Can J Microbiol 2009, 55:928-933.
61. Sharma M., Hudson J.B. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control 2008, 36:559-563.
62. Li C.S., Wang Y.C. Surface germicidal effects of ozone for microorganisms. AIHA J (Fairfax, VA) 2003, 64:533-537.